Match vs 1 year's supply of entecavir
Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
|Graham Cooke et al.|
AbstractAs NGOs consider the opportunity to scale up treatment of hepatitis B in low- to middle-income countries, it is of value to the broader community to understand the potential minimum cost of large-scale treatment for CHB using standard-of-care treatments.
Hepatitis B (HBV)
Tables & Figures
Back to top